カテゴリ： GlobalData, アメリカ, 企業調査

Cesca Therapeutics Inc (KOOL)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Cesca Therapeutics Inc (KOOL) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8013845
◆発行会社（調査会社）：GlobalData
◆発行日：2017年11月22日
◆ページ数：72
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its device division, ThermoGenesis Corp. offers the AutoXpress platform for automated clinical biobanking. The company is also developing CAR-TXpress platform for bio-manufacturing which find applications in immuno-oncology therapeutics. The company markets its products to patients, physician and partners in three target markets, namely, cellular therapeutics, medical/diagnostic device development and commercialization, and cell manufacturing and banking. Cesca is headquartered in Rancho Cordova, California, the US.

Cesca Therapeutics Inc (KOOL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
Cesca Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
Cesca Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
Cesca Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 10
Cesca Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Cesca Therapeutics Inc, Medical Equipment, Deal Details 13
Asset Purchase 13
Cesca Therapeutics Acquires Cell Processing Systems of SynGen 13
Venture Financing 14
SynGen Raises USD0.4 Million in Venture Financing 14
SynGen Raises USD0.5 Million in Venture Financing 15
SynGen Raises USD0.5 Million in Venture Financing 16
SynGen Raises USD1 Million in Venture Financing 17
SynGen Raises USD1 Million in Venture Financing 18
SynGen Raises USD1.5 Million in Financing 19
SynGen Raises USD2 Million in Financing Round 20
SynGen Raises USD2.25 Million in Venture Financing 21
SynGen Raises USD5 Million in Extended Series A Venture Financing 22
SynGen Raises USD2 Million in Venture Financing 23
SynGen to Raise Funds in Financing 24
SynGen To Raise Funds Through Venture Financing Round 25
SynGen Raises US$1 Million In Venture Financing 26
SynGen Raises US$5 Million In Series A Financing 27
Partnerships 28
Cesca Therapeutics Enters into Distribution Agreement with Boyalife 28
Texas Stem Cell Enters into Agreement with Cesca Therapeutics 29
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 30
ThermoGenesis Enters Into Co-Marketing Agreement With Golden Meditech Holdings 31
Thermogenesis Enters Into Distribution Agreement With Arthrex For Res-Q System 32
Merger 33
TotipotentRx Completes Merger With ThermoGenesis 33
Equity Offering 35
Cesca Therapeutics Prices Private Placement of Shares for USD2.5 Million 35
Cesca Therapeutics to Raise USD2.5 Million in Private Placement of Shares 36
Cesca Therapeutics Raises USD11.3 Million in Public Offering of Units 37
ThermoGenesis Completes Private Placement Of Common Stock And Warrants For US$6.7 Million 39
ThermoGenesis Completes Public Offering Of Units For US$4.5 Million 40
Debt Offering 42
Cesca Therapeutics to Raise USD12.5 Million in Private Placement of 22% Debentures Due 2019 42
Cesca Therapeutics Raises USD5.5 Million in First Tranche of Private Placement of Debentures Due 2045 43
Asset Transactions 44
Cesca Therapeutics Acquires Cell Processing Systems of SynGen 44
Helmer Acquires Thermoline Plasma Freezer And Thawer Product Line Of Thermogenesis 45
Asahi Kasei Completes Acquisition Of CryoSeal FS System From ThermoGenesis For US$2 Million 46
Cesca Therapeutics Inc – Key Competitors 48
Cesca Therapeutics Inc – Key Employees 49
Cesca Therapeutics Inc – Locations And Subsidiaries 50
Head Office 50
Other Locations & Subsidiaries 50
Recent Developments 51
Financial Announcements 51
Nov 14, 2017: Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update 51
Sep 19, 2017: Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update 53
May 11, 2017: Cesca Therapeutics Announces Fiscal Third Quarter and Nine Month 2017 Financial and Operating Results and Provides Corporate Update 54
Feb 13, 2017: Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results and Provides Business Update 56
Nov 17, 2016: Cesca Therapeutics Reports First Quarter Fiscal 2017 Results and Provides Business Update 57
Sep 20, 2016: Cesca Therapeutics Reports Fourth Quarter and Fiscal 2016 Year End Results 58
May 12, 2016: Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results and Provides Business Update 59
Feb 16, 2016: Cesca Therapeutics Reports Second Quarter Fiscal 2016 Results and Provides a Status Update to Investors 60
Corporate Communications 61
Apr 03, 2017: Cesca Therapeutics Announces Senior Management Promotions 61
Feb 28, 2017: Cesca Therapeutics Strengthens Leadership Team and Board of Directors 62
Jan 17, 2017: Cesca Therapeutics Appoints Dr. Joseph Thomis to Its Board of Directors 63
Jun 20, 2016: Cesca Therapeutics Appoints Mark Bagnall to Its Board of Directors 64
Mar 23, 2016: Cesca Therapeutics Appoints Vascular Surgery Expert Lars Norgren, M.D., Ph.D., to its Clinical Advisory Board 65
Mar 10, 2016: Cesca Therapeutics Appoints Dr. Xiaochun Xu, Chairman and CEO of Boyalife Group, to Board of Directors 66
Product News 67
Mar 20, 2017: Cesca CLI Feasibility Study Published in Peer-Reviewed Journal 67
Oct 18, 2016: Cesca Therapeutics Granted Third U.S. Patent Relating to Its Proprietary SurgWerks Platform 68
Aug 02, 2016: Cesca Therapeutics Announces Publication of Results on Use of Its Technology for Treatment of Non-Union Fracture 69
May 24, 2016: Cesca Therapeutics to Exhibit at the 2016 International Society for Cellular Therapy Annual Meeting 70
Other Significant Developments 71
Aug 24, 2017: Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN 71
Appendix 72
Methodology 72
About GlobalData 72
Contact Us 72
Disclaimer 72

List of Tables
Cesca Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Cesca Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
Cesca Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
Cesca Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
Cesca Therapeutics Inc, Deals By Market, 2011 to YTD 2017 10
Cesca Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Cesca Therapeutics Acquires Cell Processing Systems of SynGen 13
SynGen Raises USD0.4 Million in Venture Financing 14
SynGen Raises USD0.5 Million in Venture Financing 15
SynGen Raises USD0.5 Million in Venture Financing 16
SynGen Raises USD1 Million in Venture Financing 17
SynGen Raises USD1 Million in Venture Financing 18
SynGen Raises USD1.5 Million in Financing 19
SynGen Raises USD2 Million in Financing Round 20
SynGen Raises USD2.25 Million in Venture Financing 21
SynGen Raises USD5 Million in Extended Series A Venture Financing 22
SynGen Raises USD2 Million in Venture Financing 23
SynGen to Raise Funds in Financing 24
SynGen To Raise Funds Through Venture Financing Round 25
SynGen Raises US$1 Million In Venture Financing 26
SynGen Raises US$5 Million In Series A Financing 27
Cesca Therapeutics Enters into Distribution Agreement with Boyalife 28
Texas Stem Cell Enters into Agreement with Cesca Therapeutics 29
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 30
ThermoGenesis Enters Into Co-Marketing Agreement With Golden Meditech Holdings 31
Thermogenesis Enters Into Distribution Agreement With Arthrex For Res-Q System 32
TotipotentRx Completes Merger With ThermoGenesis 33
Cesca Therapeutics Prices Private Placement of Shares for USD2.5 Million 35
Cesca Therapeutics to Raise USD2.5 Million in Private Placement of Shares 36
Cesca Therapeutics Raises USD11.3 Million in Public Offering of Units 37
ThermoGenesis Completes Private Placement Of Common Stock And Warrants For US$6.7 Million 39
ThermoGenesis Completes Public Offering Of Units For US$4.5 Million 40
Cesca Therapeutics to Raise USD12.5 Million in Private Placement of 22% Debentures Due 2019 42
Cesca Therapeutics Raises USD5.5 Million in First Tranche of Private Placement of Debentures Due 2045 43
Cesca Therapeutics Acquires Cell Processing Systems of SynGen 44
Helmer Acquires Thermoline Plasma Freezer And Thawer Product Line Of Thermogenesis 45
Asahi Kasei Completes Acquisition Of CryoSeal FS System From ThermoGenesis For US$2 Million 46
Cesca Therapeutics Inc, Key Competitors 48
Cesca Therapeutics Inc, Key Employees 49
Cesca Therapeutics Inc, Other Locations 50
Cesca Therapeutics Inc, Subsidiaries 50

★海外企業調査レポート[Cesca Therapeutics Inc (KOOL)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Tata Teleservices (Maharashtra) Ltd (TTML)：企業の財務・戦略的SWOT分析
    Tata Teleservices (Maharashtra) Ltd (TTML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Sompo Japan Nipponkoa Holdings, Inc.：企業の戦略・SWOT・財務情報
    Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Integrity Applications Ltd-医療機器分野：企業M&A・提携分析
    Summary Integrity Applications Ltd (Integrity Applications) is a medical device company that designs, develops and commercializes non-invasive glucose monitoring devices. The company offers glucose monitoring devices and is used in ultrasonic, electromagnetic and thermal technologies to (non-invasiv …
  • Oriola-KD Oyj (OKDBV)：企業の財務・戦略的SWOT分析
    Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BioMarin Pharmaceutical Inc (BMRN)：製薬・医療：M&Aディール及び事業提携情報
    Summary BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals for treatment of serious diseases and medical conditions, such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasi …
  • Kerr Corp：企業の戦略的SWOT分析
    Kerr Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • IndigoVision Group plc (IND)：企業の財務・戦略的SWOT分析
    Summary IndigoVision Group plc (IndigoVision) is a developer, manufacturer and distributor of end-to-end IP security management systems. The company’s products include management software, cameras and encoders, specialized cameras, body worn video, integration and recorders. Its camera and encoder’s …
  • Medpace Inc (MEDP)：企業の財務・戦略的SWOT分析
    Summary Medpace Inc (Medpace), a subsidiary of Medpace Holdings Inc is a contract research organization that develops research based drug and medical device. The organization provides services such as medical affairs, regulatory affairs and medical writing, clinical monitoring, clinical trial manage …
  • Australian Vintage Limited：企業の戦略・SWOT・財務情報
    Australian Vintage Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Vintage Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Canadian Western Bank Group (CWB)：企業の財務・戦略的SWOT分析
    Canadian Western Bank Group (CWB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Brick Brewing Co. Limited：企業の戦略・SWOT・財務分析
    Brick Brewing Co. Limited - Strategy, SWOT and Corporate Finance Report Summary Brick Brewing Co. Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • OK Biotech Co Ltd (4155)：医療機器：M&Aディール及び事業提携情報
    Summary OK Biotech Co Ltd (OK Biotech) is a medical device manufacturing and distribution company that manufactures and distributes blood glucose monitoring devices and homecare medical products, among others. The company’s blood glucose monitoring devices include blood glucose meter systems, blood …
  • Noel Gifts International Ltd. (543)：企業の財務・戦略的SWOT分析
    Noel Gifts International Ltd. (543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • DEME NV：電力：M&Aディール及び事業提携情報
    Summary DEME N.V. (DEME), a subsidiary of Compagnie d'Entreprises CFE SA is a dredging and hydraulic engineering services company. The company offers services, which include engineering solutions, installation of offshore wind farms, services to oil and gas companies, environmental activities such a …
  • Peter’s Food Service Ltd：企業の戦略・SWOT・財務情報
    Peter's Food Service Ltd - Strategy, SWOT and Corporate Finance Report Summary Peter's Food Service Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Polyplus-Transfection SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Polyplus-Transfection SA (Polyplus) is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. The company develops RNA interference such as STICKY SIRNA and SIRNAPLUS for in vivo research. It …
  • eFFECTOR Therapeutics Inc：企業のM&A・事業提携・投資動向
    eFFECTOR Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's eFFECTOR Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Professional Insurance Corp Zambia PLC：企業の戦略・SWOT・財務分析
    Professional Insurance Corp Zambia PLC - Strategy, SWOT and Corporate Finance Report Summary Professional Insurance Corp Zambia PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • NIIT Ltd (NIITLTD)：企業の財務・戦略的SWOT分析
    NIIT Ltd (NIITLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • ACMAT Corporation：企業の戦略・SWOT・財務情報
    ACMAT Corporation - Strategy, SWOT and Corporate Finance Report Summary ACMAT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆